- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hypogonadal Males in Australia
Total 498 results
-
Corvus Pharmaceuticals, Inc.Genentech, Inc.CompletedRenal Cell Cancer | Metastatic Castration Resistant Prostate CancerUnited States, Canada, Australia
-
Kyowa Kirin Pharmaceutical Development LtdCompletedX-linked Hypophosphatemia (XLH)Sweden, Spain, United Kingdom, Italy, Austria, France
-
CelgeneCompletedProstate CancerUnited States, Spain, France, Belgium, Australia, Denmark, Austria, United Kingdom, Netherlands, Poland, Israel, Italy, Germany, Greece, Canada, Czechia, Hungary, Mexico, Russian Federation, South Africa, Sweden
-
Alexion Pharmaceuticals, Inc.CompletedParoxysmal Nocturnal HemoglobinuriaItaly, Spain, Belgium, France, Turkey, Austria, Brazil, Netherlands, Australia, Finland, Russian Federation, Sweden, Canada, United States
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstatic Neoplasms | Hormone-Refractory Prostate CancerUnited States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingRenal Cell CarcinomaPoland, Australia, United States, Canada, France, Hungary, Ireland, Italy, Korea, Republic of, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
-
LTN PHARMACEUTICALS, INC.TerminatedProstate CancerUnited States, France, Australia, Canada, Spain, United Kingdom, Italy, Belgium
-
SanofiRegeneron PharmaceuticalsCompletedProstatic Neoplasms | Neoplasm MetastasisUnited States, France, Canada, Brazil, Russian Federation, Ukraine, Australia, Netherlands, Portugal, Spain, Sweden, Switzerland, Turkey, Estonia, Singapore, Taiwan, Belgium, Czech Republic, Argentina, Denmark, Hungary, Israel, Italy, United Kingdom and more
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingUrinary Bladder Neoplasms | Muscle-Invasive Bladder CancerRussian Federation, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Finland, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Norway, Portugal, Roman... and more
-
Novartis PharmaceuticalsTerminatedLupus NephritisCzechia, Australia, Spain, Thailand, Brazil, Portugal, Vietnam, Korea, Republic of, Colombia, Guatemala, Slovakia, Philippines, Japan
-
Eledon PharmaceuticalsTerminatedIgA Nephropathy | IgANAustralia, Spain, Thailand, New Zealand, Croatia, Malaysia, Philippines, Poland, Sri Lanka, United Kingdom
-
Ethicon, Inc.RecruitingPelvic Organ Prolapse | Stress Urinary IncontinenceUnited States, Denmark, France, Germany, Poland, Sweden, Austria, Italy
-
AstraZenecaCompletedProstate CancerSweden, United States, Brazil, Czech Republic, France, Russian Federation, United Kingdom, Germany, China, Hungary, Poland, Finland, Netherlands, Mexico, Hong Kong, Australia, Belgium, Canada, Denmark, Portugal, South Africa, Korea... and more
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerCanada, United States, Spain, Australia, Denmark, Korea, Republic of, Belgium, Singapore, Finland, Netherlands, France, Austria, Germany, Israel, United Kingdom, Italy, Japan, Lithuania, Poland, Russian Federation, Slovakia, Sweden
-
Unity Health TorontoCanadian Institutes of Health Research (CIHR); The George Institute for Global...CompletedAtrial Fibrillation | End Stage Renal Failure on DialysisCanada, Australia
-
Novartis PharmaceuticalsTerminatedMelanoma | Head and Neck Cancer | Pancreatic Cancer | Urothelial Cancer | NSCLC, Non Small Cell Lung Cancer | RCC, Renal Cell Cancer | DLBCL, Diffused Large B Cell Lymphoma | MSS, Microsatellite Stable Colon Cancer | TNBC, Triple Negative Breast Cancer | mCRPC, Metastatic Castration Resistant Prostate...Belgium, Italy, Taiwan, Germany, Spain, United States, Argentina, Australia, Austria, Czechia, France, Japan, Netherlands, Switzerland, Singapore
-
Arcus Biosciences, Inc.RecruitingCervical Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Bladder Cancer | Advanced Cancer | Non-Small Cell Lung Cancer (NSCLC) | Advanced Malignancies | Renal Cell Carcinoma (RCC) | Triple Negative Breast Cancer (TNBC) | Head and Neck Squamous Cell Carcinoma (HNSCC) | Gastroesophageal-junction...United States, Australia
-
The University of QueenslandNational Health and Medical Research Council, Australia; Cambridge University... and other collaboratorsRecruitingKidney Failure, Chronic | HyperphosphatemiaCanada, United Kingdom, Australia, Brazil, New Zealand
-
Novartis PharmaceuticalsTerminatedOvarian Cancer | Non-small Cell Lung Cancer (NSCLC) | Renal Cell Carcinoma (RCC) | Triple Negative Breast Cancer (TNBC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Metastatic Castration Resistant Prostate Cancer (mCRPC) | Colorectal Cancer Microsatellite Stable (MSS)Canada, Australia, Singapore, United States, Japan, Spain, United Kingdom
-
Centocor, Inc.CompletedProstatic NeoplasmsUnited States, Poland, United Kingdom, Belgium, Germany, India, South Africa, Russian Federation, Austria, Netherlands
-
Centocor, Inc.TerminatedCancer, ProstateUnited States, United Kingdom, Belgium, Germany, Spain, France, Austria
-
HI-BioCompletedTrial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (M-PLACE)Glomerulonephritis, Membranous | antiPLA2R PositiveSpain, Belgium, Australia, Italy, United States, Korea, Republic of, France, Netherlands, Poland
-
ChemoCentryxMedpace, Inc.CompletedFocal Segmental Glomerulosclerosis | FSGS | GlomerulosclerosisUnited States, France, Italy, Australia, United Kingdom, Canada, New Zealand, Poland
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
ExelixisCompletedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerBelgium, France, Italy, Canada, United States, Germany, United Kingdom, Australia, Netherlands, Spain, Austria, Ireland, Puerto Rico, Sweden
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
Chinook Therapeutics, Inc.RecruitingImmunoglobulin A Nephropathy | IgA NephropathySpain, United States, Australia, Korea, Republic of, Brazil, Malaysia
-
BayerCompletedBone Metastases | Hormone Refractory Prostate CancerItaly, Spain, Hong Kong, Canada, United Kingdom, France, Australia, United States, Germany, Brazil, Israel, Netherlands, Norway, Belgium, Sweden, Czech Republic, Poland, Singapore, Slovakia
-
Omeros CorporationTerminatedIgA NephropathyUnited States, Argentina, Australia, Belgium, Bulgaria, Canada, Czechia, Germany, Greece, Hungary, India, Italy, Korea, Republic of, Lithuania, Poland, Singapore, Slovakia, Spain, Sweden, Taiwan, Thailand, Turkey, United Kingdom
-
Eli Lilly and CompanyActive, not recruitingUrogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditionsChina, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Mexico, Belgium, Korea, Republic of, Turkey, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
-
Foresee Pharmaceuticals Co., Ltd.CompletedProstatic NeoplasmsCzechia, United States, Poland, Austria, Germany, Lithuania, Slovakia, Taiwan
-
Central European Cooperative Oncology GroupTerminatedProstate CancerMontenegro, Slovenia, Serbia, Russian Federation, Austria, Poland, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Hungary, Lithuania, Romania, Slovakia, South Africa
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedSarcoma | Kidney Cancer | Ovarian Cancer | Metastatic Cancer | Melanoma (Skin)United States, Australia, Peru, Puerto Rico
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
Bristol-Myers SquibbNektar TherapeuticsCompletedBladder Cancer | Bladder Tumor | Muscle-Invasive Bladder CancerRussian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; Eastern Cooperative Oncology Group and other collaboratorsCompletedProstate CancerUnited States, Australia, Peru, Puerto Rico
-
Myovant Sciences GmbHCompletedA Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer (HERO)Prostate CancerUnited States, Germany, Spain, New Zealand, Brazil, Belgium, Australia, Austria, Canada, China, Denmark, Finland, France, Italy, Japan, Korea, Republic of, Netherlands, Poland, Slovakia, Sweden, Taiwan, United Kingdom
-
Prostate Cancer Clinical Trials ConsortiumRecruitingProstate CancerUnited States, Australia, Spain, Switzerland, United Kingdom, Kenya, Canada, Ireland, Barbados, Brazil, Jamaica, Nigeria, Norway, Sweden, South Africa
-
Active Biotech ABCompletedProstate CancerFrance, Poland, Ukraine, United Kingdom, United States, China, Germany, Taiwan, Spain, Belgium, Colombia, Israel, Bulgaria, India, Panama, Romania, Netherlands, Greece, Sweden, Korea, Republic of, Australia, Canada, Chile, New Zealand, ... and more
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
Telix Pharmaceuticals (Innovations) Pty LimitedCompletedClear Cell Renal Cell CarcinomaUnited Kingdom, United States, Australia, Turkey, Netherlands, Belgium, Canada, France
-
Novartis PharmaceuticalsRecruitingPrimary IgA NephropathyJapan, Korea, Republic of, United States, Denmark, France, Taiwan, Belgium, Israel, Thailand, Germany, India, Czechia, Malaysia, Argentina, Singapore, China, Australia, Norway, Turkey, United Kingdom, Brazil, Hong Kong, Netherlands, C... and more
-
SanofiCompletedProstate Cancer MetastaticUnited Kingdom, Austria, Belgium, Czechia, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Spain
-
CSL BehringCompletedDiabetic Kidney Disease (DKD)United States, Australia, New Zealand, Puerto Rico, Canada, Israel
-
Kezar Life Sciences, Inc.CompletedSystemic Lupus Erythematosus | Lupus NephritisUnited States, Australia, Mexico, Russian Federation, Colombia, Peru, Poland, Ukraine
-
AstraZenecaTerminatedProstate CancerSweden, United States, Brazil, Czech Republic, France, Italy, Peru, Russian Federation, Spain, Turkey, United Kingdom, Germany, China, Hungary, Latvia, Poland, Romania, Japan, Finland, Norway, Canada, South Africa, Argentina, Australia, Belgiu... and more
-
Janssen Research & Development, LLCCompletedProstate CancerUnited States, Australia, France, United Kingdom, Belgium, Germany, Spain, Canada, Netherlands, Greece, Sweden
-
Visterra, Inc.CompletedImmunoglobulin A Nephropathy | Glomerular Disease | IgANUnited States, Australia, Canada, Hong Kong, India, Japan, Korea, Republic of, Malaysia, Philippines, Singapore, Spain, Sri Lanka, Taiwan, Thailand, United Kingdom
-
PfizerTerminatedProstatic NeoplasmsUnited States, Canada, Spain, Belgium, Finland, Italy, Korea, Republic of, Poland, Portugal, Slovakia, Sweden, Denmark, Taiwan, China, Australia, Germany, Israel, United Kingdom, Brazil, France, Czech Republic, Peru
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyEnrolling by invitationKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey